Found: 5
Select item for more details and to access through your institution.
FTL004, an anti-CD38 mAb with negligible RBC binding and enhanced pro-apoptotic activity, is a novel candidate for treatments of multiple myeloma and non-Hodgkin lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01395-0
- By:
- Publication type:
- Article
Targeting of DDR1 with antibody‐drug conjugates has antitumor effects in a mouse model of colon carcinoma.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 9, p. 1855, doi. 10.1002/1878-0261.12520
- By:
- Publication type:
- Article
Non‐IL‐2‐blocking anti‐CD25 antibody inhibits tumor growth by depleting Tregs and has synergistic effects with anti‐CTLA‐4 therapy.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 7, p. 1285, doi. 10.1002/ijc.34823
- By:
- Publication type:
- Article
Study on the Effect of Sn, In, and Se Co-Doping on the Thermoelectric Properties of GeTe.
- Published in:
- Materials (1996-1944), 2024, v. 17, n. 3, p. 551, doi. 10.3390/ma17030551
- By:
- Publication type:
- Article
High-Throughput Screening of High-Performance Thermoelectric Materials with Gibbs Free Energy and Electronegativity.
- Published in:
- Materials (1996-1944), 2023, v. 16, n. 15, p. 5399, doi. 10.3390/ma16155399
- By:
- Publication type:
- Article